跳至主要内容
临床试验/CTRI/2024/02/062187
CTRI/2024/02/062187尚未招募4 期

Optimal dose of intrathecal dexmedetomidine as an adjuvant to hyperbaric ropivacaine in subarachnoid block in patients undergoing lower abdominal and lower limb surgeries - NI

Vinayaka Missions Research Foundation0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1) Patients scheduled for elective lower abdominal and lower limb surgeries under subarachnoid block in VMMCH, Karaikal.
  • 2) Patients of American Society of Anaesthesiologists (ASA) physical status I and II

排除标准

  • 1) Patients allergic to any of the drugs used
  • 2) Patients having any absolute contraindications for spinal anesthesia such as patient not willing raised intracranial pressure, severe hypovolemia, bleeding diathesis, local infection and cardiac respiratory, and CNS diseases
  • 3) Patients having hypertension
  • 4) Patients with obesity more than 30kg per meter square
  • 5) Patient with height less than 150cms

研究者

发起方
Vinayaka Missions Research Foundation

相似试验